Health eProfile Articles and Education
The AHRQ Question Builder App

The AHRQ Question Builder App

Helping patients and caregivers prepare for medical appointments and maximize visit time

Nathan E Botts 0 2156 Article rating: No rating

The AHRQ QuestionBuilder app helps patients and caregivers prepare for medical appointments and maximize visit time.

  1. Download the mobile app.
  2. Select or create questions to ask.
  3. Save the questions to a calendar appointment or send them to any email address so that the information is handy during medical visits.*
What are the risks associated with mobile device apps?

What are the risks associated with mobile device apps?

An article from the Cybersecurity and Infrastructure Security Agency (CISA)

Nathan E Botts 0 19313 Article rating: 5.0

This is based on an article from the Cybersecurity and Infrastructure Security Agency (CISA). CISA is the Nation’s risk advisor, working with partners to defend against today’s threats and collaborating to build a more secure and resilient infrastructure for the future. CISA provides extensive cybersecurity and infrastructure security knowledge which can assist people in applying better personal health information risk management. 

In this article, CISA explains risks associated with mobile device apps and some preventive methods that can be used to better secure your personal information.

FDA Warns People with Diabetes and Health Care Providers Against the Use of Devices for Diabetes Management Not Authorized for Sale in the United States

FDA Warns People with Diabetes and Health Care Providers Against the Use of Devices for Diabetes Management Not Authorized for Sale in the United States

An FDA Safety Communication

Nathan E Botts 0 9973 Article rating: No rating

The U.S. Food and Drug Administration (FDA) is warning health care providers and people with diabetes of risks associated with use of devices for diabetes management unauthorized for sale in the U.S., whether used alone or along with other devices. These unauthorized diabetes management devices have not been reviewed by the FDA to ensure they provide a reasonable assurance of safety and effectiveness for their intended use. Use of unauthorized devices could result in inaccurate glucose level readings or unsafe insulin dosing, which can lead to injury requiring medical intervention or death.

RSS